Human Creation Holdings, Inc.
Q3 FY2026 Financial Results Materials
Discloses the Q3 results overview. Net sales of 6,774 million yen (+7.6% YoY), operating income of 226 million yen, segment trends in SES and strategic areas, and the company’s policy and outlook. Explains contributions from multiple segments and cost factors.
Key Figures
- Net sales: 6,774百万円（ YoY +7.6% ）
- Operating income: 226百万円（ YoY -? ）
- Dividends per share: Unknown
- EPS: Unknown
AI要約
Overview of performance
Cumulative third-quarter net sales increased versus the previous quarter, reflecting steady progress for the fiscal year ending September 2026. Segments such as SES, strategic areas, and Life Shield contributed to sales and profits. The structure factors in cost controls and investments in ACF and BaaS.
Outlook and key initiatives
Optimizing the timing of revenue recognition for spot HCFAs and ACF projects, continuing development investments, and expected price increases in the SES business; continue acquiring new customers and expanding business scope. Through optimization of cost structure and reallocation of personnel, pursue higher profit stability.
Net Sales Trend
Operating Income Trend
Gross Margin Analysis
Forecast vs. Actual
Human Creation Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
